Page last updated: 2024-08-24

plerixafor and Alveolar Bone Atrophy

plerixafor has been researched along with Alveolar Bone Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bak, EJ; Kim, AR; Yoo, YJ1
Hajishengallis, G; McIntosh, ML1

Other Studies

2 other study(ies) available for plerixafor and Alveolar Bone Atrophy

ArticleYear
Distribution of neutrophil and monocyte/macrophage populations induced by the CXCR4 inhibitor AMD3100 in blood and periodontal tissue early after periodontitis induction.
    Journal of periodontal research, 2022, Volume: 57, Issue:2

    Topics: Alveolar Bone Loss; Animals; Benzylamines; Cyclams; Lipopolysaccharides; Macrophages; Mice; Monocytes; Neutrophils; Periodontitis

2022
Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment.
    Molecular oral microbiology, 2012, Volume: 27, Issue:6

    Topics: Alveolar Bone Loss; Animals; Anti-Bacterial Agents; Bacterial Load; Bacteroidaceae Infections; Benzylamines; Cyclams; Disease Models, Animal; Disease Progression; Heterocyclic Compounds; Infusion Pumps, Implantable; Mice; Mice, Inbred BALB C; Periodontitis; Porphyromonas gingivalis; Real-Time Polymerase Chain Reaction; Receptors, CXCR4

2012